AcuFocus
AqueSys
Cellutions
Cerebral Vascular Applications
Halscion  
LipoSonix
NeoVista
Neuronetics
NovaLign
Sebacia




AqueSys

Date Founded
2006

Innovation
AqueSys is developing a proprietary surgical device for the treatment of glaucoma. Glaucoma is the second leading cause of blindness worldwide and affects up to 65 million individuals.

Funding
AqueSys has raised A, B and C rounds of venture financing totaling $51 million.

Contact
9834 Research Drive
Irvine, CA 92618
949.450.0250 phone
949.450.0249 fax

 



Overview : Portfolio : Funding : Join Our Team : Contact Us